Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLSI Greenwich Lifesciences Inc

已收盘 02-25 16:00:00 EST

26.13

+1.25

+5.02%

盘后25.88

-0.25-0.96%

19:36 EST

最高26.20	最低23.89	成交量19.21万
今开24.78	昨收24.88	日振幅9.28%
总市值3.62亿	流通市值1.67亿	总股本1,385万
成交额487.46万	换手率3.01%	流通股本637.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLSI","market":"US","secType":"STK","nameCN":"Greenwich Lifesciences Inc","latestPrice":26.13,"timestamp":1772053200000,"preClose":24.88,"halted":0,"volume":192087,"hourTrading":{"tag":"盘后","latestPrice":25.88,"preClose":26.13,"latestTime":"19:36 EST","volume":5885,"amount":152283.2897,"timestamp":1772066170556,"change":-0.25,"changeRate":-0.009568,"amplitude":0.011864},"delay":0,"changeRate":0.0502411575562701,"floatShares":6374500,"shares":13854539,"eps":-1.460569,"marketStatus":"已收盘","change":1.25,"latestTime":"02-25 16:00:00 EST","open":24.78,"high":26.2,"low":23.89,"amount":4874634.826487999,"amplitude":0.092846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.460569,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772096400000},"marketStatusCode":5,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":24.88,"preHourTrading":{"tag":"盘前","latestPrice":24.77,"preClose":24.88,"latestTime":"09:25 EST","volume":822,"amount":20278.413666,"timestamp":1772029500061,"change":-0.11,"changeRate":-0.004421,"amplitude":0.032958},"postHourTrading":{"tag":"盘后","latestPrice":25.88,"preClose":26.13,"latestTime":"19:36 EST","volume":5885,"amount":152283.2897,"timestamp":1772066170556,"change":-0.25,"changeRate":-0.009568,"amplitude":0.011864},"volumeRatio":1.202272},"requestUrl":"/m/hq/s/GLSI","defaultTab":"news","newsList":[{"id":"2614084901","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.53%报23.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614084901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614084901?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:43","pubTimestamp":1771944236,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时43分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅上涨5.53%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022422435697a6e0ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022422435697a6e0ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2611785970","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大跌5.84%报26.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611785970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611785970?lang=zh_cn&edition=full","pubTime":"2026-02-13 00:11","pubTimestamp":1770912700,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时11分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下挫5.84%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130011409540f00b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130011409540f00b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2610831389","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610831389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610831389?lang=zh_cn&edition=full","pubTime":"2026-02-11 02:58","pubTimestamp":1770749939,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时58分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅跳水5.21%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211025859a494a37a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211025859a494a37a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2607988200","title":"Greenwich Lifesciences, Inc.盘中异动 早盘急速拉升5.11%报30.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607988200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607988200?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:11","pubTimestamp":1769699470,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日23时11分，Greenwich Lifesciences, Inc.股票出现波动，股价急速拉升5.11%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129231110a465525e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129231110a465525e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"1105439760","title":"Greenwich Lifesciences盘前股价飙升近16% 获FDA批准乳腺癌试验物资供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1105439760","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105439760?lang=zh_cn&edition=full","pubTime":"2026-01-22 19:34","pubTimestamp":1769081696,"startTime":"0","endTime":"0","summary":"在FDA批准其乳腺癌试验所需物资供应后，Greenwich Lifesciences Inc（GLSI）股价在盘前交易中大幅跃升近16%。这一监管进展为该公司推进GP2乳腺癌免疫疗法三期临床试验扫清了关键障碍，标志着其在肿瘤治疗领域的重要突破。市场对此反应积极，投资者看好该疗法商业化前景，推动股价呈现强劲上涨态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2603672866","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603672866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603672866?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:20","pubTimestamp":1768404018,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日23时20分，Greenwich Lifesciences, Inc.股票出现波动，股价急速拉升5.10%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114232018a4c3d5cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114232018a4c3d5cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2603542444","title":"Greenwich Lifesciences, Inc.盘中异动 大幅下挫5.17%报23.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603542444?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:36","pubTimestamp":1768228564,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时36分，Greenwich Lifesciences, Inc.股票出现异动，股价快速下挫5.17%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.35%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222360597a17640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222360597a17640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2601364086","title":"Greenwich Lifesciences, Inc.盘中异动 急速拉升5.11%报21.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601364086?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:49","pubTimestamp":1767797351,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时49分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅拉升5.11%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722491197a13383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722491197a13383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2600038865","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600038865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600038865?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:35","pubTimestamp":1767191720,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日22时35分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下跌5.34%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231223521953be08f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231223521953be08f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2592036219","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592036219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592036219?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:40","pubTimestamp":1765982421,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时40分，Greenwich Lifesciences, Inc.股票出现异动，股价快速上涨5.00%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217224021a6ae77c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217224021a6ae77c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2576144706","title":"Greenwich Lifesciences, Inc.盘中异动 快速跳水5.03%报9.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576144706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576144706?lang=zh_cn&edition=full","pubTime":"2025-10-17 00:12","pubTimestamp":1760631160,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日00时12分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅跳水5.03%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017001240a4638e1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017001240a4638e1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2570531839","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.28%报9.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570531839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570531839?lang=zh_cn&edition=full","pubTime":"2025-09-26 21:55","pubTimestamp":1758894920,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日21时55分，Greenwich Lifesciences, Inc.股票出现异动，股价急速下挫5.28%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092621552097abaf55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092621552097abaf55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2567304102","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.16%报11.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567304102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567304102?lang=zh_cn&edition=full","pubTime":"2025-09-16 03:15","pubTimestamp":1757963747,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日03时15分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅上涨5.16%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。消息层面，截至03时15分，《Noble Financial维持Greenwich LifeSciences买入评级，维持目标价45美元》资讯为影响Greenwich Lifesciences, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091603154897943470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091603154897943470&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2566984850","title":"Greenwich Lifesciences, Inc.股价拉升10.00% 市值涨1649.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566984850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566984850?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:33","pubTimestamp":1757511195,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日21时33分，Greenwich Lifesciences, Inc.股票出现异动，股价快速拉升10.00%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910213315a4c0e692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910213315a4c0e692&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4211","BK4139","BK4082","SI"],"gpt_icon":0},{"id":"2518209140","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大跌5.04%报11.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209140?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:37","pubTimestamp":1741631846,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时37分，Greenwich Lifesciences, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报11.49美元/股，成交量9322股，换手率0.07%，振幅5.21%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2517535164","title":"Greenwich Lifesciences, Inc.盘中异动 快速下挫5.44%报11.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517535164?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:49","pubTimestamp":1741272542,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时49分，Greenwich Lifesciences, Inc.股票出现波动，股价急速下挫5.44%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2516301329","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.29%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301329?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:53","pubTimestamp":1740775997,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时53分，Greenwich Lifesciences, Inc.股票出现波动，股价急速上涨5.29%。截至发稿，该股报12.15美元/股，成交量1.4511万股，换手率0.11%，振幅4.85%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2506306788","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.04%报13.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506306788?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:24","pubTimestamp":1737991477,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时24分，Greenwich Lifesciences, Inc.股票出现异动，股价急速上涨5.04%。截至发稿，该股报13.75美元/股，成交量1.1902万股，换手率0.09%，振幅4.20%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2505720299","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505720299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505720299?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:12","pubTimestamp":1737562326,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时12分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅上涨5.26%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2505191202","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505191202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505191202?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:03","pubTimestamp":1737482583,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时03分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下挫5.28%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为2.22%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.greenwichlifesciences.com","stockEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0232},{"period":"3month","weight":1.9796},{"period":"6month","weight":1.171},{"period":"1year","weight":1.0996},{"period":"ytd","weight":0.1842}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Greenwich LifeSciences, Inc.成立于2006年8月29日，是特拉华州的一家公司。该公司是一家生物制药公司，正在开发GP2，这是一种旨在预防术后乳腺癌复发的免疫疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.082906},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.023891},{"month":3,"riseRate":0.6,"avgChangeRate":0.079732},{"month":4,"riseRate":0.4,"avgChangeRate":-0.166968},{"month":5,"riseRate":0.4,"avgChangeRate":-0.034914},{"month":6,"riseRate":0.6,"avgChangeRate":0.055327},{"month":7,"riseRate":0.2,"avgChangeRate":-0.014519},{"month":8,"riseRate":0.6,"avgChangeRate":0.020316},{"month":9,"riseRate":0.2,"avgChangeRate":-0.041624},{"month":10,"riseRate":0,"avgChangeRate":-0.089083},{"month":11,"riseRate":0.666667,"avgChangeRate":0.225666},{"month":12,"riseRate":0.5,"avgChangeRate":1.139783}],"exchange":"NASDAQ","name":"Greenwich Lifesciences Inc","nameEN":"Greenwich Lifesciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Greenwich Lifesciences Inc,GLSI,Greenwich Lifesciences Inc股票,Greenwich Lifesciences Inc股票老虎,Greenwich Lifesciences Inc股票老虎国际,Greenwich Lifesciences Inc行情,Greenwich Lifesciences Inc股票行情,Greenwich Lifesciences Inc股价,Greenwich Lifesciences Inc股市,Greenwich Lifesciences Inc股票价格,Greenwich Lifesciences Inc股票交易,Greenwich Lifesciences Inc股票购买,Greenwich Lifesciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}